No Data
No Data
Ventyx Biosciences, Inc.'s (NASDAQ:VTYX) Latest 15% Decline Adds to One-year Losses, Institutional Investors May Consider Drastic Measures
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
Ventyx Biosciences Reports Q3 Financial Results and Pipeline Progress
Ventyx Biosciences Analyst Ratings
Oppenheimer Maintains Ventyx Biosciences(VTYX.US) With Buy Rating, Cuts Target Price to $9
Ventyx Biosciences (VTYX) Receives a Buy From LifeSci Capital
No Data
No Data